{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:52:38Z","timestamp":1790689958959,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81921001"],"award-info":[{"award-number":["81921001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32200949"],"award-info":[{"award-number":["32200949"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFA0803801"],"award-info":[{"award-number":["2020YFA0803801"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA0806400"],"award-info":[{"award-number":["2022YFA0806400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0800701"],"award-info":[{"award-number":["2018YFA0800701"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["BX20220021"],"award-info":[{"award-number":["BX20220021"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.apsb.2024.09.010","type":"journal-article","created":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T06:44:49Z","timestamp":1726296289000},"page":"4883-4898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Adipose ADM2 ameliorates NAFLD via promotion of ceramide catabolism"],"prefix":"10.1016","volume":"14","author":[{"given":"Pengcheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YongQiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changtao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2024.09.010_bib1","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2024.09.010_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41575-020-00408-y","article-title":"Therapeutic pipeline in nonalcoholic steatohepatitis","volume":"18","author":"Vuppalanchi","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2024.09.010_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41575-020-00366-5","article-title":"Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors","volume":"18","author":"Francque","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2024.09.010_bib4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis","volume":"22","author":"Huby","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2024.09.010_bib5","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2024.09.010_bib6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia","volume":"67","author":"Fan","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2024.09.010_bib7","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2024.09.010_bib8","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.apsb.2023.10.023","article-title":"Epigenetic modification in liver fibrosis: promising therapeutic direction with significant challenges ahead","volume":"14","author":"Liu","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.09.010_bib9","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/j.apsb.2023.01.012","article-title":"Pathophysiology of obesity and its associated diseases","volume":"13","author":"Jin","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.09.010_bib10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/hep.22350","article-title":"Visceral fat: a key mediator of steatohepatitis in metabolic liver disease","volume":"48","author":"Van der Poorten","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2024.09.010_bib11","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jhep.2021.04.013","article-title":"Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis","volume":"75","author":"Ooi","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2024.09.010_bib12","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nm.4412","article-title":"Activation of intestinal hypoxia-inducible factor 2\u03b1 during obesity contributes to hepatic steatosis","volume":"23","author":"Xie","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2024.09.010_bib13","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.tem.2015.07.006","article-title":"Ceramides\u2014lipotoxic inducers of metabolic disorders","volume":"26","author":"Chaurasia","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.apsb.2024.09.010_bib14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jbior.2018.11.004","article-title":"Alcoholic and non-alcoholic fatty liver disease: focus on ceramide","volume":"70","author":"Nikolova-Karakashian","year":"2018","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.apsb.2024.09.010_bib15","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/j.apsb.2021.10.001","article-title":"Disruption of adipocyte HIF-1\u03b1 improves atherosclerosis through the inhibition of ceramide generation","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.09.010_bib16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1172\/JCI76738","article-title":"Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease","volume":"125","author":"Jiang","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.apsb.2024.09.010_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142865","article-title":"Suppressing the intestinal farnesoid X receptor\/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis","volume":"131","author":"Wu","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.apsb.2024.09.010_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2019.09.016","article-title":"Adipocyte hypoxia-inducible factor 2alpha suppresses atherosclerosis by promoting adipose ceramide catabolism","volume":"30","author":"Zhang","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2024.09.010_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cmet.2015.07.019","article-title":"The ART of lowering ceramides","volume":"22","author":"Summers","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2024.09.010_bib20","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41586-022-05299-4","article-title":"Gut bacteria alleviate smoking-related NASH by degrading gut nicotine","volume":"610","author":"Chen","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2024.09.010_bib21","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.peptides.2004.05.021","article-title":"Intermedin, a novel calcitonin family peptide that exists in teleosts as well as in mammals: a comparison with other calcitonin\/intermedin family peptides in vertebrates","volume":"25","author":"Chang","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.apsb.2024.09.010_bib22","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/bph.13814","article-title":"Adrenomedullin 2\/intermedin: a putative drug candidate for treatment of cardiometabolic diseases","volume":"175","author":"Zhang","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.apsb.2024.09.010_bib23","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1074\/jbc.M305332200","article-title":"Intermedin is a calcitonin\/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor\/receptor activity-modifying protein receptor complexes","volume":"279","author":"Roh","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2024.09.010_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104785","article-title":"Adrenomedullin 2\/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin2 G protein\u2013coupled receptor","volume":"299","author":"Babin","year":"2023","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2024.09.010_bib25","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.peptides.2005.11.004","article-title":"Immunocytochemical localization of adrenomedullin 2\/intermedin-like immunoreactivity in human hypothalamus, heart and kidney","volume":"27","author":"Takahashi","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.apsb.2024.09.010_bib26","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.2337\/db15-1626","article-title":"Adrenomedullin 2 improves early obesity-induced adipose insulin resistance by inhibiting the class II major histocompatibility complex in adipocytes","volume":"65","author":"Zhang","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.apsb.2024.09.010_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.peptides.2012.07.011","article-title":"Intermedin ameliorates atherosclerosis in ApoE null mice by modifying lipid profiles","volume":"37","author":"Zhang","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.apsb.2024.09.010_bib28","doi-asserted-by":"crossref","first-page":"23390","DOI":"10.1074\/jbc.M116.735563","article-title":"Adrenomedullin 2 enhances beiging in white adipose tissue directly in an adipocyte-autonomous manner and indirectly through activation of M2 macrophages","volume":"291","author":"Lv","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2024.09.010_bib29","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s11427-014-4701-7","article-title":"Intermedin\/adrenomedullin2: an autocrine\/paracrine factor in vascular homeostasis and disease","volume":"57","author":"Ni","year":"2014","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.apsb.2024.09.010_bib30","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bbrc.2004.12.071","article-title":"Effects of\u00a0intermedin(1\u201353) on cardiac function and ischemia\/reperfusion injury in isolated rat hearts","volume":"327","author":"Yang","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2024.09.010_bib31","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/ijo.2016.2","article-title":"Intermedin\/adrenomedullin 2 polypeptide promotes adipose tissue browning and reduces high-fat diet-induced obesity and insulin resistance in mice","volume":"40","author":"Zhang","year":"2016","journal-title":"Int J Obes"},{"key":"10.1016\/j.apsb.2024.09.010_bib32","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1210\/en.2010-0136","article-title":"Identification and characterization of a promoter cassette conferring adipocyte-specific gene expression","volume":"151","author":"Wang","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.apsb.2024.09.010_bib33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cmet.2011.02.005","article-title":"Transcriptional control of adipose lipid handling by IRF4","volume":"13","author":"Eguchi","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2024.09.010_bib34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2478\/jtim-2021-0025","article-title":"Effects of des-acyl ghrelin on insulin sensitivity and macrophage polarization in adipose tissue","volume":"9","author":"Yuan","year":"2021","journal-title":"J Transl Int Med"},{"key":"10.1016\/j.apsb.2024.09.010_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101742","article-title":"Homocysteine promotes hepatic steatosis by activating the adipocyte lipolysis in a HIF1\u03b1\u2013ERO1\u03b1-dependent oxidative stress manner","volume":"37","author":"Yan","year":"2020","journal-title":"Redox Biol"},{"key":"10.1016\/j.apsb.2024.09.010_bib36","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1172\/JCI66062","article-title":"Dexamethasone-induced Kr\u00fcppel-like factor 9 expression promotes hepatic gluconeogenesis and hyperglycemia","volume":"129","author":"Cui","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.apsb.2024.09.010_bib37","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ebiom.2018.04.022","article-title":"Adipocyte-derived lysophosphatidylcholine activates adipocyte and adipose tissue macrophage Nod-like receptor protein 3 inflammasomes mediating homocysteine-induced insulin resistance","volume":"31","author":"Zhang","year":"2018","journal-title":"EBioMed"},{"key":"10.1016\/j.apsb.2024.09.010_bib38","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/apm.12742","article-title":"Non-alcoholic fatty liver disease\u2014histological scoring systems: a large cohort single-center, evaluation study","volume":"125","author":"Rastogi","year":"2017","journal-title":"APMIS"},{"key":"10.1016\/j.apsb.2024.09.010_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"Huang","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.apsb.2024.09.010_bib40","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1016\/j.apsb.2024.09.010_bib41","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00018-022-04401-3","article-title":"Contribution of specific ceramides to obesity-associated metabolic diseases","volume":"79","author":"Hammerschmidt","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.apsb.2024.09.010_bib42","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1158\/0008-5472.CAN-15-0708","article-title":"PI3K\u2013mTORC2 but not PI3K\u2013mTORC1 regulates transcription of HIF2A\/EPAS1 and vascularization in neuroblastoma","volume":"75","author":"Mohlin","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2024.09.010_bib43","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1541-7786.MCR-13-0682","article-title":"A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1\u03b1 and HIF2\u03b1 stability and tumor growth, angiogenesis, and metastasis","volume":"12","author":"Joshi","year":"2014","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.apsb.2024.09.010_bib44","doi-asserted-by":"crossref","first-page":"40341","DOI":"10.1074\/jbc.M605077200","article-title":"Depletion of cAMP-response element-binding protein\/ATF1 inhibits adipogenic conversion of 3T3-L1 cells ectopically expressing CCAAT\/enhancer-binding protein (C\/EBP) alpha, C\/EBP beta, or PPAR gamma 2","volume":"281","author":"Fox","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2024.09.010_bib45","doi-asserted-by":"crossref","first-page":"30800","DOI":"10.1074\/jbc.M111.244780","article-title":"The acetylase\/deacetylase couple CREB-binding protein\/Sirtuin 1 controls hypoxia-inducible factor 2 signaling","volume":"287","author":"Chen","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2024.09.010_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1204907","article-title":"\u03b2-CATENIN stabilizes HIF2 through lncRNA and inhibits intravenous immunoglobulin immunotherapy","volume":"14","author":"Nakagawa","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2024.09.010_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.peptides.2013.05.002","article-title":"Intermedin enhances sympathetic outflow via receptor-mediated cAMP\/PKA signaling pathway in nucleus tractus solitarii of rats","volume":"47","author":"Li","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.apsb.2024.09.010_bib48","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1016\/j.apsb.2024.05.014","article-title":"Schisanhenol ameliorates non-alcoholic fatty liver disease via inhibiting miR-802 activation of AMPK-mediated modulation of hepatic lipid metabolism","volume":"14","author":"Li","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.09.010_bib49","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cmet.2015.06.007","article-title":"Targeted induction of ceramide degradation leads to improved systemic metabolism and reduced hepatic steatosis","volume":"22","author":"Xia","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2024.09.010_bib50","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2337\/db16-0663","article-title":"An intestinal farnesoid X receptor\u2013ceramide signaling axis modulates hepatic gluconeogenesis in mice","volume":"66","author":"Xie","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.apsb.2024.09.010_bib51","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","article-title":"Bile acids: regulation of synthesis","volume":"50","author":"Chiang","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.apsb.2024.09.010_bib52","doi-asserted-by":"crossref","first-page":"H1131","DOI":"10.1152\/ajpheart.00877.2011","article-title":"Intermedin elicits a negative inotropic effect in rat papillary muscles mediated by endothelial-derived nitric oxide","volume":"302","author":"Pires","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.apsb.2024.09.010_bib53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/164_2015_32","article-title":"Role of the cAMP pathway in glucose and lipid metabolism","volume":"233","author":"Ravnskjaer","year":"2016","journal-title":"Handb Exp Pharmacol"}],"updated-by":[{"DOI":"10.1016\/j.apsb.2024.12.022","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000}}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524003733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524003733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T02:41:30Z","timestamp":1744512090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383524003733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2211383524003733"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2024.09.010","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adipose ADM2 ameliorates NAFLD via promotion of ceramide catabolism","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2024.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}